Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

37.06
+1.123.13%
Volume:414
Turnover:15.19K
Market Cap:2.78M
PE:- -
High:37.09
Open:36.11
Low:36.11
Close:35.93
52wk High:45.88
52wk Low:25.71
Shares:75.00K
Float Shares:75.00K
Volume Ratio:0.79
T/O Rate:0.55%
Dividend:0.76
Dividend Rate:2.06%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Reuters
·
Sep 28

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Reuters
·
Sep 28

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

TIPRANKS
·
Sep 28

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 28

EBR Systems advances FDA approval process for new WiSE manufacturing site

TIPRANKS
·
Sep 28

Regeneron (REGN) Receives a Hold from Bernstein

TIPRANKS
·
Sep 26

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

TIPRANKS
·
Sep 26

Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.

Dow Jones
·
Sep 26

US FDA Approves Mirum's Drug for Rare Bone Disorder

Reuters
·
Sep 26

Regeneron Steps Into Obesity Drug Race With New Phase 1 Study

TIPRANKS
·
Sep 26

Argenx Advances Empasiprubart Into Phase 2 for Guillain-Barré: What Investors Should Watch

TIPRANKS
·
Sep 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

TIPRANKS
·
Sep 25

Vertex Minerals Sets October General Meeting for Shareholders

TIPRANKS
·
Sep 25

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Reuters
·
Sep 25

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Dow Jones
·
Sep 25

Regeneron to Report Q3 Results, Host Conference Call and Webcast

Reuters
·
Sep 25

Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026

GlobeNewswire
·
Sep 25

Regeneron Approaching Incremental Catalysts Like Upcoming Olatorepatide Data Readout, RBC Says

MT Newswires Live
·
Sep 24